icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Effect of the combination of the HBV core inhibitor NVR 3-778 with Nucleoside Analogs or other HBV core inhibitors on the inhibition of HBV DNA Replication in HepG2.2.15 cells
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
A Lam, C Espiritu, L Flores, G Hartman, and K Klumpp
Novira Therapeutics Inc., Doylestown, PA, USA
 
First patient study is ongoing.

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif